J. Domagala-Kulawik (Warsaw, Poland), D. Bouros (Athens, Greece)
Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
V. V. Vucinic, S. D. Filipovic, V. Zugic, J. L. Videnovic, J. Maric, B. Gvozdenovic (Beograd, Serbia And Montenegro)
|  |
Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis
G. Ongen, H. Ikitimur, B. Musellim (Istanbul, Turkey)
| |
The yield of endobronchial biopsy in pulmonary sarcoidosis
P. Pazarli, O. Yazicioglu Mocin, O. Aktas, T. Karagöz (Cankiri, Istanbul, Turkey)
| |
Complex tissue verification for interstitial lung diseases and perspectives of videothoracoscopic biopsy
A. K. Pismenyy, E. A. Korimasov, I. M. Fedorin (Samara, Russian Federation)
| |
Systemic manifestations of sarcoidosis
E. B. Vladimirova, V. V. Romanov, E. I. Shmelev (Moscow, Russian Federation)
| |
Pneumopathy to thalidomide
H. Afif, N. Benouhoud, A. Aichane, Z. Bouayad (Casablanca, Morocco)
| |
Outcome of two patients with lymphangioleiomyomatosis without anti-estrogen therapy
F. Kanat, T. Teke (Konya, Turkey)
| |
Extrensic allergic alveolitis in differential diagnosis of diffuse micronodular appearance
I. Koca, E. T. Putun, N. Kalac, S. Kaya, E. Ozaydin, H. Erturk (Ankara, Turkey)
| |
A novel therapy for a rare disease: endogenous lipoid pneumonia due to Niemann Pick disease type B
H. K. Ramadan, C. I. Mackinlay, A. G. Nicholson (Swindon, London, United Kingdom)
| |
Bronchiolitis obliterans organizing pneumonia in idiopathic fashion: a report from NIRTLD
S. Fallah Tafti, A. Fakharian, S. Karimi, D. Faridian Eragh (Tehran, Italy)
| |
Sarcoidosis recognised by open lung biopsy
J. Grudny, E. Wiatr, R. Langfort, P. Rudzinski, T. Orlowski, I. Bestry, K. Roszkowski-Sliz (Warsaw, Poland)
| |
Autopsy-proven causes of widespread or diffuse pulmonary infiltrates in patients with pulmonary pathology: 5 years experience
I. V. Liskina, E. I. Suslov, L. M. Zagaba (Kiev, Ukraine)
| |
Scale of fatigue – analysis in quality of life in sarcoidosis
S. D. Filipovic, V. D. Vucinic, J. V. Videnovic, J. D. Maric, T. N. Adzic, V. V. Zugic (Belgrade, Serbia And Montenegro)
| |
Assessment of quality of life in patients with sarcoidosis
V. V. Kraeva, B. M. Kornev, E. A. Kogan, E. N. Popova, V. V. Denguin (Moscow, Russian Federation)
| |
Bronchiolitis obliterans-organizing pneumonia (BOOP): clinico-laboratory study of 13 cases
E. Kastanakis, K. Paschalaki, I. Mihailidou, S. Legaki, K. Tsakanika, M. Patentalakis, N. Karagiannidis, V. Polychronopoulos (Athens, Greece)
| |
Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure
G. Pitsiou, I. Trigonis, E. Tsiata, P. Kontou, N. Manolakoglou, I. Stanopoulos, E. Mavrofridis, P. Argyropoulou (Thessaloniki, Greece)
| |
Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease
V. Fijacko, J. Kristek, M. Fijacko, B. Dobrosevic, J. Pavela (Osijek, Croatia)
| |
Diagnostic defects in interstitial lung diseases
I. B. Viktorova, A. L. Khanin (Novokuznetsk, Russian Federation)
| |
Static and dynamic lung compliance in patients with pulmonary fibrosis
M. R. Refini, G. Ciarleglio, M. G. Pieroni, E. Vlad, P. Rottoli (Siena, Italy)
| |
Etiologic factors in patients with systemic sclerosis
G. Ongen, H. Ikitimur, B. Musellim (Istanbul, Turkey)
| |
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
S. N. Ampikaipakan, A. B. Jones, A. Wilkes, J. J. Curtin, O. P. Twebtyman (Norwich, United Kingdom)
| |
Antidepressants overdose-induced lung disease
N. Mogulkoc, D. Atasever, R. Savas, A. Veral (Izmir, Turkey)
| |
Biochemical markers of connective tissue damage at chronic toxic fibrosing alveolitis
Z. K. Mazhitova, K. K. Orinbasarova (Almaty, Kazakhstan)
| |
Morphological features of interstitial damage of children‘s lungs in conditions of atmospheric air pollution
Z. K. Mazhitova, R. Z. Seisebayeva, G. A. Mergenova (Almaty, Kazakhstan)
| |
The 6 minute walk test as a tool to predict survival in patients with IPF
R. A. Baumgartner, H. H. Leuchte, C. Neurohr, C. Eggler, J. Behr (Munich, Germany)
| |
Clinical features of cryptogenic and secondary organizing pneumonia in Iceland
G. Gudmundsson, O. A. Sveinsson, H. J. Isaksson (Reykjavik, Iceland)
| |
Evaluation of interstitial inflammatory cell in idiopathic interstitial pneumonias
E. R. Parra, E. Eher, V. L. Capelozzi (São Paulo, Brazil)
| |
The incidence of gastro-oesophageal reflux (GER) in interstitial lung diseases (ILD)
P. Mika, M. Bukowczan, J. Soja, K. Sladek (Cracow, Poland)
| |
Static and dynamic compliance in patients with scleroderma and normal lung function
M. G. Pieroni, G. Ciarleglio, M. R. Refini, G. Mauro, R. Paola, S. Piersante (Siena, Italy)
| |
Pulmonary manifestations in patients with rheumatoid arthritis
C. A. Parpaglione, D. R. Rey, V. Cardozzo Pacheco, J. A. Gonzalez (Buenos Aires, Argentina)
| |
Clinical and morphological features of the pulmonary epithelioid hemangioendothelioma (intravascular sclerosing bronchoalveolar tumor)
I. V. Dvorakovskaya, L. N. Novikova, O. P. Baranova (Saint Petersburg, Russian Federation)
| |
Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry
A. B. Jones, S. N. Ampikaipakan, A. Wilkes, J. J. Curtin, O. P. Twentyman (Norwich, United Kingdom)
| |
Interstitial lung disease (ILD) and gastroesophageal reflux (GER)
G. Belmonte, B. Salvioli, L. Fasano, A. M. G. Pacilli, V. Di Scioscio, V. Stanghellini, E. Baldi, P. Carbonara, R. Corinaldesi, M. Fabbri (Bologna, Italy)
| |
Serum KL-6 level is increased in patients with pneumocystis pneumonia
S. Hirata, A. Yokoyama, H. Ohnishi, Y. Haruta, N. Ishikawa, K. Fujitaka, Y. Taooka, N. Hattori, H. Hamada, K. Nishimura, N. Kohno (Hiroshima, Toon, Japan; Denver, United States Of America)
| |